Following this line of thought, we found that ANRIL could regulate the miR-7-5p/PARP1 axis in the cytoplasm through website prediction and experimental verification, thereby affecting the radiosensitivity of lung cancer cells. Here, CDKN2B-AS1 is linked to lung carcinoma.